Randomized Trial Assessing the Effects of Ergocalciferol Administration on Circulating FGF23

BACKGROUND AND OBJECTIVES: Fibroblast growth factor 23 is a phosphate- and vitamin D–regulating hormone. The objective of this study was to determine the effect of ergocalciferol administration on fibroblast growth factor 23 levels in healthy vitamin D–deficient subjects. DESIGN, SETTING, PARTICIPAN...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Burnett-Bowie, Sherri-Ann M., Leder, Benjamin Z., Henao, Maria P., Baldwin, Chantel M., Hayden, Douglas L., Finkelstein, Joel S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Nephrology 2012
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3315336/
https://ncbi.nlm.nih.gov/pubmed/22300739
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.10030911
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak